Oncology
400mg Imatib Imatinib Tablets IP
Imatib Imatinib
Imatib Imatinib (400mg) oral solid — targeted therapy for chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). WHO-GMP certified, export-ready.
Dosage
400mg
Composition
Imatib Imatinib 400mg
Packaging
10 Tablets per strip
Manufacturer
NexCure Health
$24.84per tablet
In Stock — Ships within 24hrs
Worldwide shipping
CoA included
Quantity:
1
💡 Bulk pricing available — Contact us for orders of 100+ units for additional discounts. All orders include Certificate of Analysis and export documentation.
Manufactured by NexCure Health, 400mg Imatib Imatinib Tablets IP is a pharmaceutical-grade targeted therapy product containing Imatib Imatinib 400mg. The active ingredient functions as a tyrosine kinase inhibitor that blocks BCR-ABL fusion protein activity, making it effective for chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). This product is produced under strict GMP conditions with complete batch traceability. Export-ready with Certificate of Analysis, stability data, and documentation required for international pharmaceutical import.
